Cargando…

Tolerability and Patient/Physician Satisfaction with Subcutaneously Administered Methotrexate Provided in Two Formulations of Different Drug Concentrations in Patients with Rheumatoid Arthritis

OBJECTIVES: To determine preference, satisfaction, usability and local tolerability by patients, physicians and study nurses of two subcutaneously administered methotrexate (MTX) formulations of different concentrations. METHODS: This was an open-label, comparative, within-patient controlled, multic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller-Ladner, Ulf, Rockwitz, Karin, Brandt-Jürgens, Jan, Haux, Roland, Kästner, Peter, Braun, Jürgen, Demary, Winfried, Guimbal-Schmolck, Cécile, Pichlmeier, Uwe, Brandt, Andreas
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866241/ https://www.ncbi.nlm.nih.gov/pubmed/20461222 http://dx.doi.org/10.2174/1874312901004010015

Ejemplares similares

Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience
por: Demary, Winfried, et al.
Publicado: (2014)

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis
por: Pachon, Jaime A, et al.
Publicado: (2014)

Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
por: Tzaribachev, N, et al.
Publicado: (2008)

Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients
por: Luo, Man (Melody), et al.
Publicado: (2020)

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial
por: Shabbir, Shaila, et al.
Publicado: (2019)

Bioavailability of IgG Administered by the Subcutaneous Route
por: Berger, Melvin, et al.
Publicado: (2013)

Patient’s experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19()()
por: Smith, Tiffany Joyce, et al.
Publicado: (2023)

A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate
por: Smolen, Josef S, et al.
Publicado: (2017)

Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction
por: Ahmed, Hamdy MA, et al.
Publicado: (2018)

Pharmacokinetic/Pharmacodynamic Dosage Individualization of Suppressive Beta-Lactam Therapy Administered by Subcutaneous Route in Patients With Prosthetic Joint Infection
por: Goutelle, Sylvain, et al.
Publicado: (2021)

A phase I study of subcutaneously administered aflibercept (VEGF trap) in a new formulation in patients with advanced solid tumors
por: Wang-Gillam, Andrea, et al.
Publicado: (2011)

Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
por: Curtis, J. R., et al.
Publicado: (2016)

Testicular prostheses in patients with testicular cancer - acceptance rate and patient satisfaction
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2015)

Formulation and In Vitro Evaluation of Ufasomes for Dermal Administration of Methotrexate
por: Sharma, Arvind, et al.
Publicado: (2012)

Absorption Kinetics of Subcutaneously Administered Ceftazidime in Hypoperfused Guinea Pigs
por: Ebihara, Tsuyoshi, et al.
Publicado: (2014)

Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers
por: Collins, D. S., et al.
Publicado: (2017)

Factors Affecting the Absorption of Subcutaneously Administered Insulin: Effect on Variability
por: Gradel, A. K. J., et al.
Publicado: (2018)

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
por: Schäfer, Martin, et al.
Publicado: (2020)

Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
por: Branco, Jaime C., et al.
Publicado: (2016)

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation
por: Meier, Juris J.
Publicado: (2021)

Novel formulation of a methotrexate derivative with a lipid nanoemulsion
por: Moura, Juliana A, et al.
Publicado: (2011)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study
por: Braun, Jürgen, et al.
Publicado: (2011)

Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep
por: Woodland, Alyssa N., et al.
Publicado: (2019)

Pharmacokinetics of multivesicular liposomal encapsulated cytarabine when administered subcutaneously in dogs
por: Vazquez Fuster, Irene B., et al.
Publicado: (2020)

Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations
por: Tchobaniouk, Lesia V, et al.
Publicado: (2019)

Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine
por: Karer, Matthias, et al.
Publicado: (2022)

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
por: Deodhar, Atul, et al.
Publicado: (2015)

The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients – preliminary report
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2018)

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
por: Schiff, Michael H, et al.
Publicado: (2014)

Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery
por: Latif, Muhammad Shahid, et al.
Publicado: (2022)

Orally administered liposomal formulations for colon targeted drug delivery
por: Hua, Susan
Publicado: (2014)

Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate
por: Okada, Akie, et al.
Publicado: (2022)

Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis
por: Iwami, Eri, et al.
Publicado: (2019)

Formulation and Characterization of Alginate-Based Membranes for the Potential Transdermal Delivery of Methotrexate
por: Bajas, Dorothea, et al.
Publicado: (2021)

Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity
por: Maiti, Debarati, et al.
Publicado: (2023)

Case of Snake-Bite Treated by Means of Liquor Ammoniæ, Administered Subcutaneously and Internally
por: Hogan, G.
Publicado: (1874)

Tralokinumab pharmacokinetics and tolerability when administered by different subcutaneous injection methods and rates
por: Jain, Meena, et al.
Publicado: (2017)

The Pharmacokinetics of Medetomidine Administered Subcutaneously during Isoflurane Anaesthesia in Sprague-Dawley Rats
por: Kint, Leila T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_obq4tfdptmgmvpmkn0qkat2gp7